← Open Payments lookup

AMMON LOTT: Open Payments

NPI 1902489032 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$289 in 16 payments from 8 companies in 2025. Trend: 2023 $260 · 2024 $364 · 2025 $289

Food & beverage: $289
CompanyPaymentsAmount
ABBVIE INC.4$78
Otsuka America Pharmaceutical, Inc.3$53
Lilly USA, LLC3$45
Novartis Pharmaceuticals Corporation1$31
Organon LLC2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Novo Nordisk Inc1$18
SANOFI-AVENTIS U.S. LLC1$17

Products named: QULIPTA, REXULTI, MOUNJARO, LEQVIO, NEXPLANON, UBRELVY, XIFAXAN, Ozempic.

Industry payments across UT — which companies pay providers there.